Billings Clinic
Especially For:

Clinical Trials

Title   Symptom Managment (RTOG 1012): Manuka Honey to Treat Esophagitis-Related Pain During Lung Cancer Treatment
Description   "A Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis-Related Pain During the Treatment of Lung Cancer"
IRB Number   RTOG 1012
Category   Symptom Management
Inclusion/Notes   Patients being treated with combination chemotherapy (definitive or adjuvant) and radiation therapy once daily for small cell or non-small cell lung cancer; at least 5 cm of the esophagus must be in the 60 Gy isodose volume in 1.6 to 2.0 Gy fractions (to insure there's signifcant risk of esophagitis among patients).

Exclusion criteria (may not be an all-inclusive list): ~metastatic disease; ~inability to swallow thick liquids prior to treatment; ~known hypersensitivity to honey; ~prior chemotherapy or radiation treatments; ~more than once daily treatments; ~poorly controlled diabetes; ~inability to complete required forms
Status   Temp Closed
Start Date   08/13/2012
Principal Investigator (PI)   John Schallenkamp, MD
Physician Profile   Radiation Oncologist
Contact Name   Susan Dillon, RN
Contact Email   sdillon1@billingsclinic.org
Phone   (406) 435-7443
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.